RxDoctor Payments Data

Adebola Nnewihe, MD

Gynecology · Northfield, NJNPI 1154530301

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 33 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Evofem Biosciences, Inc. at 28.0% of the total. Reporting peaked in 2021 at $208 and has fallen 78.8% since, to $44 in 2025. That places this record below the midpoint for gynecology clinicians in NJ, where the typical reported total is $456.

$489in general payments, 2019–2025

Across 33 payments — averaging $14.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Evofem Biosciences, Inc.$137
  • AbbVie$85
  • Hologic Sales And Service, LLC$59
  • Astellas Pharma US Inc$34
  • Exeltis, USA Inc.$31
  • Sumitomo Pharma America, Inc.$30
  • plus $113 from 6 others

What the payments were for

  • Food & beverage$489100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$489 in reported general payments places this provider in the 50th percentile of 97 gynecology providers in New Jersey.

See all gynecology providers in New Jersey

Medicare billing

Part B allowed, 2024
$23,365
Medicare patients
90
Services billed
276

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ibandronate Sodium11$536

Paid to pharmacies, not to this prescriber.

Other gynecology in Northfield

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →